Literature DB >> 9509916

Surgical treatment of intestinal Behçet's disease.

K S Lee1, S J Kim, B C Lee, D S Yoon, W J Lee, H S Chi.   

Abstract

From 1983 to 1994, we diagnosed 37 cases of intestinal Behçet's disease and performed operations on 26 patients at the Surgical Department of Yonsei University Medical Center. Sixty percent of patients were in their teens and twenties (mean age: 36.4 years). Preoperative diagnosis of Behçet's disease was correctly made in only 8 cases (30%). In 32 cases (86.5%), the lesion was localized regardless of the number of ulcers. A solitary ulcer was observed in 22 cases (60%), while multiple ulcers were present in 15 cases. A recurrence after the initial operation was observed in 12 patients (46.1%) and reoperation was performed 19 times. Fifty percent of recurrence developed within 2 years after each operation. The type of operation, the location of lesion and the number of ulcers did not appear to be related to the recurrence. As a preoperative diagnosis is difficult and the recurrence rate is high, post- operative periodic follow-up with radiography and endoscopy are strongly recommended. At the time of operation, the entire bowel should be examined and bowel resection should include a generous normal resection margin as well as skip lesions.

Entities:  

Mesh:

Year:  1997        PMID: 9509916     DOI: 10.3349/ymj.1997.38.6.455

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  11 in total

1.  A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.

Authors:  Heiner Wedemeyer; Jens G Kuipers; Konrad Streetz; Michael Mengel; Ingolf Schedel; Nikolina Kezmic; Peter Meier; Henning Zeidler; Michael P Manns; Siegfried Wagner
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 2.  Evaluation of current therapeutic strategies in Behçet's disease.

Authors:  Iliana Alexoudi; Violetta Kapsimali; Aristides Vaiopoulos; Meletios Kanakis; George Vaiopoulos
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

Review 3.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

4.  Behçet's disease combined with various types of fistula.

Authors:  Hye Jin Chung; Bon Cheol Goo; Ju Hee Lee; Dongsik Bang; Kwang Hoon Lee; Eun-So Lee; Sungnack Lee
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

5.  Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms.

Authors:  Seung-Ho Rhee; Young-Bae Kim; Eun-So Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

6.  Prediction of free bowel perforation in patients with intestinal Behçet's disease using clinical and colonoscopic findings.

Authors:  Chang Mo Moon; Jae Hee Cheon; Jae Kook Shin; Soung Min Jeon; Hyun Jung Bok; Jin Ha Lee; Jae Jun Park; Sung Pil Hong; Tae Il Kim; Nam Kyu Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

7.  Intestinal perforations in Behçet's disease.

Authors:  Shao-Jiun Chou; Victor Tze-Kai Chen; Hsiang-Chun Jan; Mary Ann Lou; Yi-Ming Liu
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

8.  Behçet's disease physiopathology: a contemporary review.

Authors:  Mohamad J Zeidan; David Saadoun; Marlene Garrido; David Klatzmann; Adrien Six; Patrice Cacoub
Journal:  Auto Immun Highlights       Date:  2016-02-12

9.  Ileocecal ulcer with a cecocecal fistula in Behçet's disease.

Authors:  H K Chang; J S Kim; H R Chung
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

Review 10.  Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?

Authors:  Duk Hwan Kim; Jae Hee Cheon
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.